|
|
.
See Category: Neoplasms
See Header: Benign carcinoid tumors of other sites
ICD-10 (CM) Code and Descriptor
|
D3A.092 |
Benign carcinoid tumor of the stomach
|
D3A092 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 47.79%
|
17.69%
|
10.49%
|
6.85%
|
4.92%
|
3.28%
|
1.71%
|
1.64%
|
1.21%
|
1.43%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D3A.092*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
205
|
205
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
192
|
192
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
169
|
169
|
|
80053
|
COMPREHEN METABOLIC PANEL |
166
|
166
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
152
|
280
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
126
|
3,556
|
|
86316
|
IMMUNOASSAY TUMOR OTHER |
125
|
126
|
|
88342
|
IMHCHEM/IMCYTCHM 1ST ANTB |
121
|
167
|
|
88341
|
IMHCHEM/IMCYTCHM EA ADD ANTB |
98
|
258
|
|
43239
|
EGD BIOPSY SINGLE/MULTIPLE |
93
|
93
|
|
96372
|
THER/PROPH/DIAG INJ SC/IM |
92
|
111
|
|
82941
|
ASSAY OF GASTRIN |
70
|
70
|
|
J2353
|
OCTREOTIDE INJECTION, DEPOT |
63
|
1,640
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
56
|
5,200
|
|
82607
|
VITAMIN B-12 |
56
|
56
|
|
82728
|
ASSAY OF FERRITIN |
50
|
50
|
|
74177
|
CT ABD & PELVIS W/CONTRAST |
43
|
43
|
|
83540
|
ASSAY OF IRON |
43
|
43
|
|
J7120
|
RINGERS LACTATE INFUSION |
43
|
48
|
|
J3420
|
VITAMIN B12 INJECTION |
36
|
36
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D3A.092 related to the following DRG Codes:
393-395
|
